Literature DB >> 25215007

Prognostic significance of urokinase-type plasminogen activator and its receptor in patients with systemic inflammatory response syndrome.

Li Yu1, Ding Long1, Xiao-Ling Wu1, Jun-Hui Yang1, Yuan-Chao Yang1, Geng Feng1.   

Abstract

BACKGROUND: This study aimed to determine the plasma levels of urokinase-type plasminogen activator (uPA), urokinase-type plasminogen activator receptor (uPAR), D-dimer, IL-6 and TNF-α and observe the relations among uPA, uPAR, D-dimer, IL-6 and TNF-α in patients with systemic inflammatory response syndrome (SIRS).
METHODS: A prospective, clinical case-control study was conducted in patients with SIRS at age of more than 55 years old treated during 2008-2010 at Wuhan Central Hospital. Venous blood samples were collected by routine venipuncture. Eighty-five patients were divided into two groups according to diagnostic criteria of SIRS: SIRS patients from intensive care units (n=50), and non-SIRS patients from medical wards (n=35). Thirty healthy blood donors who visited the General Health Check-up Division at Wuhan Central Hospital served as controls. Excluded from the study were (1) those patients with pregnancy; (2) those with cancer; (3) those died after admission into the ICU in 7 days; (4) those received cardiopulmonary resuscitation; (5) those who had previous blood system diseases; and (6) those with SIRS before admission into the ICU. The levels of uPA, uPAR, D-D, IL-6 and TNF-α in blood were detected by commercial enzyme-linked immunosorbent assay (ELISA) kit. The data were analyzed using SPSS version 17.0 and expressed as mean ± standard. Student's t test and the Mann-Whitney U test were used in the analysis. The relations of uPA, uPAR and D-dimer, IL-6 TNF-α levels were analyzed using Spearman's rank-order correlation coefficient test.
RESULTS: The plasma levels of uPA, uPAR, D-dimer,IL-6 and TNF-α in the patients with SIRS were obviously higher than those in the non-SIRS patients and controls (P<0.001). Correlation analysis showed a positive correlation between uPAR and IL-6 levels (r=0.395, P=0.004) and between uPAR and TNF-α levels (r=0.606, P<0.001), but no correlation between uPAR and D-dimer levels (r=0.069, P=0.632). No correlation was observed between uPA, D-dimer, IL-6 and TNF-α levels (P>0.05). The establishment of ROC curve was based on the levels of uPAR, D-dimer, IL-6 and TNF-α in 24 hours for the diagnosis of multiple organ dysfunction syndrome (MODS), and the ROC areas under the curve were 0.76, 0.58, 0.86 and 0.83, respectively.
CONCLUSIONS: uPA and uPAR play a major role in patients with SIRS in the process of coagulation disorder, but the mechanism of SIRS is not the same. uPAR may play a central role in the development of SIRS to MODS.

Entities:  

Keywords:  Coagulant function; D-dimer; Interleukin-6; Multiple organ dysfunction syndrome; Systemic inflammatory response syndrome; Tumor necrosis factor-alpha

Year:  2011        PMID: 25215007      PMCID: PMC4129706          DOI: 10.5847/wjem.j.1920-8642.2011.03.005

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  20 in total

1.  The effect of activated protein C on plasma cytokine levels in a porcine model of acute endotoxemia.

Authors:  Jeppe Sylvest Nielsen; Anders Larsson; Thomas Rix; Rasmus Nyboe; Jakob Gjedsted; Jan Krog; Thomas Ledet; Else Tønnesen
Journal:  Intensive Care Med       Date:  2007-04-25       Impact factor: 17.440

2.  Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.

Authors:  Anita W Rijneveld; Marcel Levi; Sandrine Florquin; Peter Speelman; Peter Carmeliet; Tom van Der Poll
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

3.  Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.

Authors:  Tatsuyori Shozushima; Gaku Takahashi; Naoya Matsumoto; Masahiro Kojika; Yoshikazu Okamura; Shigeatsu Endo
Journal:  J Infect Chemother       Date:  2011-05-12       Impact factor: 2.211

4.  [Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease].

Authors:  Maciej Kohut; Marek Hartleb; Teresa Hartleb
Journal:  Pol Merkur Lekarski       Date:  2010-09

Review 5.  Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.

Authors:  Thomas Münzel; Christoph Sinning; Felix Post; Ascan Warnholtz; Eberhard Schulz
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

6.  Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.

Authors:  Hidesaku Asakura; Hideo Wada; Kohji Okamoto; Toshiaki Iba; Toshimasa Uchiyama; Yutaka Eguchi; Kazuo Kawasugi; Shin Koga; Toshihiko Mayumi; Kaoru Koike; Satoshi Gando
Journal:  Thromb Haemost       Date:  2006-02       Impact factor: 5.249

Review 7.  Inflammatory markers in SIRS, sepsis and septic shock.

Authors:  I Herzum; H Renz
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 8.  Sepsis and multiple organ failure.

Authors:  Michael R Pinsky
Journal:  Contrib Nephrol       Date:  2007       Impact factor: 1.580

9.  [Expression of urokinase-type plasminogen activator and its receptor in plasma of patients with cerebral infarction].

Authors:  Shui-jiang Song; Jun-bin Hu; Hong-xiang Wang; Shu-qun Wen; Mei-ping Ding; Jian-zheng Huang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2003-09-25

10.  Hemostasis and inflammation: two of a kind?

Authors:  Peter Verhamme; Marc F Hoylaerts
Journal:  Thromb J       Date:  2009-11-18
View more
  3 in total

1.  Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients.

Authors:  Sofia C Ramos; Augusto J de Matos; João Niza Ribeiro; Liliana R Leite-Martins; Rui R F Ferreira; Inês Viegas; Andreia A Santos
Journal:  Vet World       Date:  2017-08-14

2.  Serum Urokinase-Type Plasminogen Activator Receptor Does Not Outperform C-Reactive Protein and Procalcitonin as an Early Marker of Severity of Acute Pancreatitis.

Authors:  Witold Kolber; Beata Kuśnierz-Cabala; Paulina Dumnicka; Małgorzata Maraj; Małgorzata Mazur-Laskowska; Michał Pędziwiatr; Piotr Ceranowicz
Journal:  J Clin Med       Date:  2018-09-27       Impact factor: 4.241

3.  Urokinase-type plasminogen activator receptor as a predictor of poor outcome in patients with systemic inflammatory response syndrome.

Authors:  Xiao-Ling Wu; Ding Long; Li Yu; Jun-Hui Yang; Yuan-Chao Zhang; Feng Geng
Journal:  World J Emerg Med       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.